Key Highlights
- An evening market update listed a UBS Buy rating on Amazon with a $340 target.
- Amazon was up 0.9% at $260.10 in pre-market trading on Wednesday, November 18.
- A $340 target would sit about 30% above that level.
- Amazon closed Tuesday at $257.89, holding up better than many tech peers.
Amazon (NASDAQ:AMZN) has a reported analyst endorsement in its corner as it heads into Wednesday's session.
What has been reported
An evening market update on November 17 listed a UBS (NYSE:UBS) Buy rating on Amazon with a $340 price target among its linked items.
How the stock is trading
Amazon was up 0.9% at $260.10 in pre-market trading on Wednesday, November 18, according to market data. A $340 target would sit about 30% above that level. No company announcement explains the move, which appears to track the broader AI relief rally after Nvidia (NASDAQ:NVDA)'s results.
Why it matters for the Dow
Amazon joined the Dow Jones Industrial Average in 2024. The Dow fell 848.75 points on Tuesday. Amazon closed that day at $257.89, roughly flat, holding up better than many tech peers, according to market data.
What would confirm the UBS call
Watch for confirmation of the UBS call, and for how Amazon trades as the biggest AI spenders lag hardware suppliers. Anthropic, which has received Investment from Amazon in the past, is expected to price its IPO on Wednesday evening.
FAQs
Q: What was reported about Amazon and UBS?
A: An evening market update listed a UBS Buy rating on Amazon with a $340 price target among its linked items.
Q: How is AMZN trading pre-market?
A: It was up 0.9% at $260.10 on Wednesday, November 18, tracking the broader AI relief rally after Nvidia's results.
Q: How far above the current price is the target?
A: A $340 target would sit about 30% above the pre-market level.
Q: What should investors watch?
A: Whether the UBS call is confirmed, how Amazon trades as the biggest AI spenders lag hardware suppliers, and Anthropic's IPO pricing.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.